Install
FirstWord
- 79articles · 30d
- 20+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 68
- Health 56
- Health & Wellness 51
- Business & Industrial 26
- Economy, Business & Finance 17
- Finance & Business 9
- Science & Technology 5
- Arts, Culture, Entertainment & Media 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Vital Signs: Tracking the trials and tribulations ahead for CVOTs
3+ day, 21+ hour ago (11+ words) firstwordpharma.com...
AbbVie aims to expand Qulipta's label into new migraine market
3+ day, 19+ hour ago (12+ words) FirstWord PHARMA...
Animal data trigger enrollment pause in Biohaven's epilepsy study
3+ day, 23+ hour ago (11+ words) FirstWord PHARMA...
NodThera rebrands as Rezera, charts registrational path for PAD drug
4+ day, 12+ hour ago (12+ words) FirstWord Pharma...
Physician Views Results: Neurologists express cautious optimism for BTK inhibitors in MS
5+ day, 5+ hour ago (14+ words) FirstWord Pharma...
Tyra remains upbeat after oral bladder cancer drug misses study expectations
5+ day, 5+ hour ago (13+ words) FirstWord Pharma...
Kura spins out Caspian to take menin inhibitor into diabetes
5+ day, 7+ hour ago (12+ words) FirstWord Pharma...
Shionogi's regeneration-inducing drug comes up short in acute ischemic stroke study
5+ day, 9+ hour ago (13+ words) FirstWord Pharma...
Inhibrx touts HNSCC subgroup data, eyes accelerated pathway for OX40 agonist
5+ day, 19+ hour ago (13+ words) FirstWord Pharma...
Evommune ends oral drug's dermatitis programme after second mid-stage setback
5+ day, 12+ hour ago (12+ words) FirstWord Pharma...